|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNISA996339109903316 |
|
|
Autore |
Smith Graeme |
|
|
Titolo |
Problem Solving in Haematology [[electronic resource]] |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Oxford, : Clinical Publishing, 2010 |
|
|
|
|
|
|
|
ISBN |
|
1-282-70154-1 |
9786612701542 |
1-84692-605-X |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (210 p.) |
|
|
|
|
|
|
Collana |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Blood -- Diseases |
Hematologic Diseases |
Hematology |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di contenuto |
|
Contents; Contributors; Abbreviations; Section 1: Introduction; Problem 01: The approach to the patient with anabnormal blood count; Section 2: Haemostasis and Thrombosis; Problem 02: Anticoagulation; Problem 03: Bleeding in an intensive therapy unitpatient; Problem 04: Investigation of easy bruising; Problem 05: Inherited disorders of coagulation; Problem 06: Thrombophilia; Section 3: Red Cell Disorders and Aplastic Anaemia; Problem 07: The investigation of anaemia and theanaemia of chronic disease; Problem 08: Aplastic anaemia; Problem 09: Paroxysmal nocturnal haemoglobinuria |
Problem 10: Sickle cell diseaseProblem 11: ß-Thalassaemia major; Section 4: Clinical Blood Transfusion; Problem 12: Acute haemolytic transfusion reaction(ABO incompatibility); Problem 13: Massive blood transfusion; Problem 14: Refractoriness to platelet transfusion; Problem 15: Transfusion-related acute lung injury; Section 5: Acute and Chronic Leukaemia andMyelodysplasia; Problem 16: Acute myeloid leukaemia; Problem 17: Paediatric acute lymphoblasticleukaemia; Problem 18: Adult acute lymphoblastic leukaemia; Problem 19: Chronic lymphocytic leukaemia - earlystage disease |
Problem 20: Chronic lymphocytic leukaemia -advanced stage diseaseProblem 21: Chronic myeloid leukaemia; Problem 22: Low-risk |
|
|
|
|